{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T16:00:50Z","timestamp":1789920050521,"version":"4.0.1"},"posted":{"date-parts":[[2026,9,20]]},"group-title":"In Review","reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,8,4]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Background:<\/bold>\n                  Women at high risk for breast cancer include those with pathogenic variants in hereditary breast cancer predisposition genes, high-risk benign breast lesions, or a lifetime risk over 20% based on validated models.\n                  <bold\/>\n                  Supplemental breast MRI screening improves early detection and reduces interval cancers in high-risk women. Despite recommendations from professional organizations for breast MRI screening among high-risk women, uptake remains low. To better understand breast MRI utilization, we conducted a qualitative study exploring healthcare provider and patient perspectives to inform development of a screening module within our patient-facing web-based decision aid,\n                  <italic>RealRisks<\/italic>\n                  .\n                  <bold>Methods:<\/bold>\n                  We conducted semi-structured interviews with 20 women at high risk for breast cancer and 17 healthcare providers at an urban academic medical center in New York City. All interviews were transcribed verbatim and coded using Dedoose software. Transcripts were analyzed thematically to identify patterns in clinician communication strategies, MRI screening practices, as well as barriers and facilitators shaping implementation.\n                  <bold>Results:<\/bold>\n                  All enrolled providers were female, including six primary care providers (PCPs), five gynecologists, four breast radiologists, and two cancer genetic counselors. Among enrolled patients, mean age was 51.8 years (SD, 14.8) and 40% were Hispanic, 40% non-Hispanic White, 10% non-Hispanic Black, and 10% other. More than half of providers (59%) had ordered a breast MRI for high-risk patients, and 55% of patients had previously undergone MRI screening. The three themes that emerged included: 1) responsibility in initiating MRI screening was fragmented across specialties; 2) patients and providers encountered barriers at every step of the screening process, including knowledge gaps and uncertainty about insurance coverage; 3) both groups identified a need for clearer, consolidated guidelines and accessible resources to support informed decision-making.\n                  <bold>Conclusion:<\/bold>\n                  Our findings highlight the need to address structural and communication barriers to improve MRI screening uptake among high-risk women and their providers\n                  <bold>.<\/bold>\n                  Integrating electronic medical record (EMR)-based risk assessment and patient educational materials into clinical workflows may support informed, shared decision-making. Future work will involve design and usability testing of the\n                  <italic>RealRisks<\/italic>\n                  screening module, which will be available in English and Spanish and tailored to patients with varying health literacy and educational backgrounds.\n                <\/p>","DOI":"10.21203\/rs.3.rs-10591503\/v1","type":"posted-content","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:11:41Z","timestamp":1789917101000},"source":"Crossref","is-referenced-by-count":0,"title":["Fragmented ownership and multilevel barriers to breast MRI screening among high-risk women: A qualitative study informing development of clinical decision support"],"prefix":"10.21203","author":[{"given":"Marlee","family":"Pincus","sequence":"first","affiliation":[{"name":"Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Law","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Ro","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hijiya","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Kukafka","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine D","family":"Crew","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Michel","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"17","key":"ref1","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3390\/cancers13174287","article-title":"Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review","volume":"13","author":"\u0141ukasiewicz S","year":"2021","unstructured":"\u0141ukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanis\u0142awek A. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers. 2021;13(17):4287. 10.3390\/cancers13174287 . PubMed PMID: 34503097; PubMed Central PMCID: PMC8428369.","journal-title":"Cancers"},{"issue":"2","key":"ref2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.6004\/jnccn.2026.0007","article-title":"NCCN Guidelines\u00ae Insights: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026","volume":"24","author":"Cheng HH","year":"2026","unstructured":"Cheng HH, Giri VN, Goggins M, Yurgelun MB, Karlan BY, Norquist BS, et al. NCCN Guidelines\u00ae Insights: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026. J Natl Compr Cancer Netw JNCCN. 2026;24(2):2\u201310. 10.6004\/jnccn.2026.0007 . PubMed PMID: 41671423.","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"issue":"11","key":"ref3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.46747\/cfp.6911748","article-title":"Breast density notification: Are family doctors prepared to counsel patients on risks and management?","volume":"69","author":"Wilkinson AN","year":"2023","unstructured":"Wilkinson AN. Breast density notification: Are family doctors prepared to counsel patients on risks and management? Can Fam Physician Med Fam Can. 2023;69(11):748\u201350. 10.46747\/cfp.6911748 . PubMed PMID: 37963789; PubMed Central PMCID: PMC10645451.","journal-title":"Can Fam Physician Med Fam Can"},{"issue":"2","key":"ref4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1148\/radiol.2021203633","article-title":"Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE Trial","volume":"299","author":"Veenhuizen SGA","year":"2021","unstructured":"Veenhuizen SGA, de Lange SV, Bakker MF, Pijnappel RM, Mann RM, Monninkhof EM, et al. Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE Trial. Radiology. 2021;299(2):278\u201386. 10.1148\/radiol.2021203633 . PubMed PMID: 33724062.","journal-title":"Radiology"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S1470-2045(19)30275-X","article-title":"MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial","volume":"20","author":"Saadatmand S","year":"2019","unstructured":"Saadatmand S, Geuzinge HA, Rutgers EJT, Mann RM, de Roy DBW, Zonderland HM, et al. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial. Lancet Oncol. 2019;20(8):1136\u201347. (19)30275-X PubMed PMID: 31221620.","journal-title":"Lancet Oncol"},{"issue":"9","key":"ref6","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/jama.2025.24784","article-title":"Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial","volume":"335","author":"Esserman LJ","year":"2026","unstructured":"Esserman LJ, Fiscalini AS, Naeim A, Van \u2018T, Veer LJ, Kaster A, Scheuner MT, et al. Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial. JAMA. 2026;335(9):763. 10.1001\/jama.2025.24784.","journal-title":"JAMA"},{"issue":"11","key":"ref7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.6004\/jnccn.2025.0053","article-title":"NCCN Guidelines\u00ae Insights: Breast Cancer, Version 5.2025: Featured Updates to the NCCN Guidelines","volume":"23","author":"Gradishar WJ","year":"2025","unstructured":"Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. NCCN Guidelines\u00ae Insights: Breast Cancer, Version 5.2025: Featured Updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2025;23(11):426\u201336. 10.6004\/jnccn.2025.0053.","journal-title":"J Natl Compr Canc Netw"},{"issue":"11S","key":"ref8","doi-asserted-by":"publisher","first-page":"S508","DOI":"10.1016\/j.jacr.2025.08.044","article-title":"ACR Appropriateness Criteria\u00ae Female Breast Cancer Screening: 2025 Update","volume":"22","author":"Yeh ED","year":"2025","unstructured":"Expert Panel on Breast Imaging, Yeh ED, Brown A, Freer PE, Bahl M, Bennett DL, et al. ACR Appropriateness Criteria\u00ae Female Breast Cancer Screening: 2025 Update. J Am Coll Radiol JACR. 2025;22(11S):S508\u201330. 10.1016\/j.jacr.2025.08.044 . PubMed PMID: 41193041.","journal-title":"J Am Coll Radiol JACR"},{"issue":"22","key":"ref9","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1001\/jama.2024.5534","article-title":"Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement","volume":"331","author":"Nicholson WK","year":"2024","unstructured":"US Preventive Services Task Force, Nicholson WK, Silverstein M, Wong JB, Barry MJ, Chelmow D, et al. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2024;331(22):1918. 10.1001\/jama.2024.5534.","journal-title":"JAMA"},{"issue":"11suppl","key":"ref10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1200\/OP.2023.19.11_suppl.133","article-title":"Uptake of screening MRI in high risk patients without a personal history of breast cancer","volume":"19","author":"Boccuzzi L","year":"2023","unstructured":"Boccuzzi L, Paul S, McPeek C, Stempel L, Alvarado R, Levy MA, et al. Uptake of screening MRI in high risk patients without a personal history of breast cancer. JCO Oncol Pract. 2023;19(11suppl):133\u2013133. 10.1200\/OP.2023.19.11_suppl.133.","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"ref11","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/tbj.13063","article-title":"Factors associated with breast MRI use among women with a family history of breast cancer","volume":"24","author":"White MC","year":"2018","unstructured":"White MC, Soman A, Weinberg CR, Rodriguez JL, Sabatino SA, Peipins LA, et al. Factors associated with breast MRI use among women with a family history of breast cancer. Breast J. 2018;24(5):764\u201371. 10.1111\/tbj.13063 . PubMed PMID: 29781100; PubMed Central PMCID: PMC6141343.","journal-title":"Breast J"},{"issue":"10","key":"ref12","doi-asserted-by":"publisher","first-page":"6219","DOI":"10.1245\/s10434-023-13903-8","article-title":"Breast Cancer Risk Assessment and Screening Practices Reported Via an Online Survey","volume":"30","author":"Record SM","year":"2023","unstructured":"Record SM, Thomas SM, Chanenchuk T, Baker JA, Grimm LJ, Plichta JK. Breast Cancer Risk Assessment and Screening Practices Reported Via an Online Survey. Ann Surg Oncol. 2023;30(10):6219\u201329. 10.1245\/s10434-023-13903-8 . PubMed PMID: 37460738; PubMed Central PMCID: PMC10528282.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"ref13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/cncr.29805","article-title":"Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status","volume":"122","author":"Haas JS","year":"2016","unstructured":"Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, et al. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. 2016;122(4):611\u20137. 10.1002\/cncr.29805 . PubMed PMID: 26709819; PubMed Central PMCID: PMC4742376.","journal-title":"Cancer"},{"issue":"7","key":"ref14","doi-asserted-by":"publisher","first-page":"e2222092","DOI":"10.1001\/jamanetworkopen.2022.22092","article-title":"Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial","volume":"5","author":"Kukafka R","year":"2022","unstructured":"Kukafka R, Pan S, Silverman T, Zhang T, Chung WK, Terry MB, et al. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial. JAMA Netw Open. 2022;5(7):e2222092. 10.1001\/jamanetworkopen.2022.22092 . PubMed PMID: 35849397; PubMed Central PMCID: PMC9294997.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"ref15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1158\/1940-6207.CAPR-22-0013","article-title":"Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial","volume":"15","author":"Crew KD","year":"2022","unstructured":"Crew KD, Bhatkhande G, Silverman T, Amenta J, Jones T, McGuinness JE, et al. Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial. Cancer Prev Res (Phila Pa). 2022;15(10):689\u2013700. 10.1158\/1940-6207.CAPR-22-0013 . PubMed PMID: 35679576; PubMed Central PMCID: PMC9532364.","journal-title":"Cancer Prev Res (Phila Pa)"},{"issue":"6","key":"ref16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1158\/1940-6207.CAPR-21-0593","article-title":"Strategies to Identify and Recruit Women at High Risk for Breast Cancer to a Randomized Controlled Trial of Web-based Decision Support Tools","volume":"15","author":"McGuinness JE","year":"2022","unstructured":"McGuinness JE, Bhatkhande G, Amenta J, Silverman T, Mata J, Guzman A, et al. Strategies to Identify and Recruit Women at High Risk for Breast Cancer to a Randomized Controlled Trial of Web-based Decision Support Tools. Cancer Prev Res (Phila Pa). 2022;15(6):399\u2013406. 10.1158\/1940-6207.CAPR-21-0593 . PubMed PMID: 35412592; PubMed Central PMCID: PMC9167698.","journal-title":"Cancer Prev Res (Phila Pa)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"100433","DOI":"10.1016\/j.conctc.2019.100433","article-title":"Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention","volume":"16","author":"Crew KD","year":"2019","unstructured":"Crew KD, Silverman TB, Vanegas A, Trivedi MS, Dimond J, Mata J, et al. Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention. Contemp Clin Trials Commun. 2019;16:100433. 10.1016\/j.conctc.2019.100433 . PubMed PMID: 31497674; PubMed Central PMCID: PMC6722284.","journal-title":"Contemp Clin Trials Commun"},{"issue":"6","key":"ref18","doi-asserted-by":"publisher","first-page":"CD013185","DOI":"10.1002\/14651858.CD013185.pub2","article-title":"Risk prediction models for familial breast cancer","volume":"6","author":"McGarrigle SA","year":"2026","unstructured":"McGarrigle SA, Hanhauser YP, Mockler D, Gallagher DJ, Kennedy MJ, Damen JA, et al. Risk prediction models for familial breast cancer. Cochrane Database Syst Rev. 2026;6(6):CD013185. 10.1002\/14651858.CD013185.pub2 . PubMed PMID: 42223121; PubMed Central PMCID: PMC13224777.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"ref19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems","volume":"12","author":"Atkins L","year":"2017","unstructured":"Atkins L, Francis J, Islam R, O\u2019Connor D, Patey A, Ivers N, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci IS. 2017;12(1):77. 10.1186\/s13012-017-0605-9 . PubMed PMID: 28637486; PubMed Central PMCID: PMC5480145.","journal-title":"Implement Sci IS"},{"issue":"13","key":"ref20","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample Size in Qualitative Interview Studies: Guided by Information Power","volume":"26","author":"Malterud K","year":"2016","unstructured":"Malterud K, Siersma VD, Guassora AD. Sample Size in Qualitative Interview Studies: Guided by Information Power. Qual Health Res. 2016;26(13):1753\u201360. doi:10.1177\/1049732315617444 PubMed PMID: 26613970.","journal-title":"Qual Health Res"},{"issue":"2","key":"ref21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun V","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101. 10.1191\/1478088706qp063oa.","journal-title":"Qual Res Psychol"},{"issue":"1","key":"ref22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10549-024-07471-","article-title":"Barriers and facilitators to breast cancer screening among high-risk women: a qualitative study","volume":"209","author":"Conley CC","year":"2025","unstructured":"Conley CC, Anderson A, Rodriguez JD, Kang H, Taylor EP, Luck C, et al. Barriers and facilitators to breast cancer screening among high-risk women: a qualitative study. Breast Cancer Res Treat. 2025;209(1):61\u201371. 10.1007\/s10549-024-07471-. y PubMed PMID: 39190231; PubMed Central PMCID: PMC11786993.","journal-title":"Breast Cancer Res Treat"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"106927","DOI":"10.1016\/j.ypmed.2021.106927","article-title":"The association between adherence to cancer screening programs and health literacy: A systematic review and meta-analysis","volume":"155","author":"Baccolini V","year":"2022","unstructured":"Baccolini V, Isonne C, Salerno C, Giffi M, Migliara G, Mazzalai E, et al. The association between adherence to cancer screening programs and health literacy: A systematic review and meta-analysis. Prev Med. 2022;155:106927. 10.1016\/j.ypmed.2021.106927 . PubMed PMID: 34954244.","journal-title":"Prev Med"},{"issue":"15","key":"ref24","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1002\/cam4.3218","article-title":"Breast cancer supplemental screening: Women\u2019s knowledge and utilization in the era of dense breast legislation","volume":"9","author":"Aminawung JA","year":"2020","unstructured":"Aminawung JA, Hoag JR, Kyanko KA, Xu X, Richman IB, Busch SH, et al. Breast cancer supplemental screening: Women\u2019s knowledge and utilization in the era of dense breast legislation. Cancer Med. 2020;9(15):5662\u201371. 10.1002\/cam4.3218.","journal-title":"Cancer Med"},{"issue":"1","key":"ref25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12911-018-0716-5","article-title":"Pilot study of decision support tools on breast cancer chemoprevention for high-risk women and healthcare providers in the primary care setting","volume":"18","author":"Kukafka R","year":"2018","unstructured":"Kukafka R, Fang J, Vanegas A, Silverman T, Crew KD. Pilot study of decision support tools on breast cancer chemoprevention for high-risk women and healthcare providers in the primary care setting. BMC Med Inf Decis Mak. 2018;18(1):134. 10.1186\/s12911-018-0716-5 . PubMed PMID: 30558581; PubMed Central PMCID: PMC6296071.","journal-title":"BMC Med Inf Decis Mak"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10591503\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10591503\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:11:42Z","timestamp":1789917102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10591503\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,20]]},"references-count":25,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10591503\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,9,20]]},"subtype":"preprint"}}